Reactions Weekly

, Volume 1635, Issue 1, pp 12–12 | Cite as

UGT1A1*28 genotyping reduces irinotecan toxicity costs

Clinical study
  • 20 Downloads

Reference

  1. Roncato R, et al. Cost evaluation of irinotecan-related toxicities associated with the UGT1A1*28 patient genotype. Clinical Pharmacology and Therapeutics : 11 Jan 2017. Available from: URL: http://doi.org/10.1002/cpt.615

Copyright information

© Springer International Publishing Switzerland 2017

Personalised recommendations